Center for Drug Design - University of Minnesota

The Center for Drug Design was conceived by Robert Vince, Ph.D., medicinal chemist and researcher at the University of Minnesota. He is the holder of more than 20 patents in the anti-cancer, anti-viral, and anti-microbial fields, and is now the director of the Center. One of his most significant contributions was the design of carbovir, a potent anti-HIV/AIDS drug. This led to the establishment of the Center for Drug Design on January 8, 2002. At that time, Senior Vice President, Frank Cerra, MD, and the Council of Deans of the Academic Health Center at the University of Minnesota voted on...

Providing a research environment for leading scientists,developing novel drug therapies,vigorously pursuing an academic research agenda,designing & developing new medicines,supporting the interaction of many disciplines,and creating a focal point for research

Center for drug design - university of minnesota operates in the Research services industry.

Center for drug design - university of minnesota's revenue is 11m - 100m

Center for drug design - university of minnesota has 11 - 50 employees.